| scholarly article | Q13442814 |
| P2093 | author name string | M Sandberg | |
| W Hammerschmidt | |||
| B Sugden | |||
| P2860 | cites work | A novel RING finger protein interacts with the cytoplasmic domain of CD40 | Q24306382 |
| A novel member of the TRAF family of putative signal transducing proteins binds to the cytosolic domain of CD40 | Q24306620 | ||
| Involvement of CRAF1, a relative of TRAF, in CD40 signaling | Q24306746 | ||
| Presence of a new conserved domain in CART1, a novel member of the tumor necrosis factor receptor-associated protein family, which is expressed in breast carcinoma | Q24315735 | ||
| TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways | Q24317441 | ||
| A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor | Q24318280 | ||
| Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein | Q24599252 | ||
| The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit | Q27860669 | ||
| CD30 contains two binding sites with different specificities for members of the tumor necrosis factor receptor-associated factor family of signal transducing proteins | Q28281794 | ||
| The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family | Q28307399 | ||
| TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40 | Q28610812 | ||
| Epstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-kappa B activity | Q30452167 | ||
| Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population | Q30794609 | ||
| Transcriptional activation of the tumor necrosis factor alpha-inducible zinc finger protein, A20, is mediated by kappa B elements | Q30990490 | ||
| Stimulation of NF-kappa B-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus | Q35838888 | ||
| The Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor. | Q35841701 | ||
| Epstein-Barr virus LMP1 induction of the epidermal growth factor receptor is mediated through a TRAF signaling pathway distinct from NF-kappaB activation | Q35875444 | ||
| Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation | Q36564433 | ||
| Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation | Q36575274 | ||
| Transformation by the oncogenic latent membrane protein correlates with its rapid turnover, membrane localization, and cytoskeletal association | Q36695348 | ||
| Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts | Q36696963 | ||
| Processing of the Epstein-Barr virus-encoded latent membrane protein p63/LMP | Q36801187 | ||
| The transforming domain alone of the latent membrane protein of Epstein-Barr virus is toxic to cells when expressed at high levels | Q36827992 | ||
| Orientation and patching of the latent infection membrane protein encoded by Epstein-Barr virus | Q36861507 | ||
| Posttranslational processing of an Epstein-Barr virus-encoded membrane protein expressed in cells transformed by Epstein-Barr virus | Q36885739 | ||
| Posttranslational processing of the Epstein-Barr virus-encoded p63/LMP protein | Q36889566 | ||
| Nucleotide sequence of an mRNA transcribed in latent growth-transforming virus infection indicates that it may encode a membrane protein | Q36893502 | ||
| CD30/TNF receptor-associated factor interaction: NF-kappa B activation and binding specificity | Q37360807 | ||
| All three domains of the Epstein-Barr virus-encoded latent membrane protein LMP-1 are required for transformation of rat-1 fibroblasts. | Q40044497 | ||
| The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. | Q41371042 | ||
| Upregulation of bcl-2 by the Epstein-Barr virus latent membrane protein LMP1: a B-cell-specific response that is delayed relative to NF-kappa B activation and to induction of cell surface markers | Q41447311 | ||
| Effect of beta-lymphocyte- and NPC-derived EBV-LMP1 gene expression on in vitro growth and differentiation of human epithelial cells | Q41465786 | ||
| Clonability and tumorigenicity of human epithelial cells expressing the EBV encoded membrane protein LMP1. | Q41549956 | ||
| Morphological transformation of human keratinocytes expressing the LMP gene of Epstein Barr virus | Q41733704 | ||
| Transformation of Balb 3T3 cells by the BNLF-1 gene of Epstein-Barr virus | Q41976287 | ||
| DNA sequence analysis of the EcoRI Dhet fragment of B95-8 Epstein-Barr virus containing the terminal repeat sequences | Q45807158 | ||
| Transformation of foetal human keukocytes in vitro by filtrates of a human leukaemic cell line containing herpes-like virus | Q45814517 | ||
| TANK, a co-inducer with TRAF2 of TNF- and CD 40L-mediated NF-kappaB activation | Q48064873 | ||
| An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. | Q53541156 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 8 | |
| P304 | page(s) | 4649-4656 | |
| P577 | publication date | 1997-06-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Characterization of LMP-1's association with TRAF1, TRAF2, and TRAF3 | |
| P478 | volume | 71 |
| Q40117245 | A membrane leucine heptad contributes to trafficking, signaling, and transformation by latent membrane protein 1. |
| Q33759787 | A new domain in the Toll/IL-1R domain-containing adaptor inducing interferon-β factor protein amino terminus is important for tumor necrosis factor-α receptor-associated factor 3 association, protein stabilization and interferon signaling |
| Q39606109 | Activation of TRAF5 and TRAF6 signal cascades negatively regulates the latent replication origin of Epstein-Barr virus through p38 mitogen-activated protein kinase |
| Q24683297 | Activation of mitogen-activated protein kinase and NF-kappaB pathways by a Kaposi's sarcoma-associated herpesvirus K15 membrane protein |
| Q33825713 | An Epstein-Barr virus that expresses only the first 231 LMP1 amino acids efficiently initiates primary B-lymphocyte growth transformation |
| Q42937211 | Analysis of the Epstein-Barr virus (EBV) latent membrane protein 1 (LMP-1) gene and promoter in Hodgkin's disease isolates: selection against EBV variants with mutations in the LMP-1 promoter ATF-1/CREB-1 binding site |
| Q39645275 | CD40 and LMP-1 both signal from lipid rafts but LMP-1 assembles a distinct, more efficient signaling complex |
| Q38782732 | CD63 Regulates Epstein-Barr Virus LMP1 Exosomal Packaging, Enhancement of Vesicle Production, and Noncanonical NF-κB Signaling |
| Q33813615 | Control of cell cycle entry and apoptosis in B lymphocytes infected by Epstein-Barr virus. |
| Q36369236 | Differential signaling and tumor necrosis factor receptor-associated factor (TRAF) degradation mediated by CD40 and the Epstein-Barr virus oncoprotein latent membrane protein 1 (LMP1). |
| Q38869012 | Epstein - Barr virus Latent Membrane Protein 1 suppresses reporter activity through modulation of promyelocytic leukemia protein-nuclear bodies |
| Q58803477 | Epstein-Barr Virus-Associated Malignancies: Roles of Viral Oncoproteins in Carcinogenesis |
| Q39604074 | Epstein-Barr virus LMP-1 natural sequence variants differ in their potential to activate cellular signaling pathways. |
| Q33887684 | Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade |
| Q35291650 | Epstein-Barr virus latent-infection membrane proteins are palmitoylated and raft-associated: protein 1 binds to the cytoskeleton through TNF receptor cytoplasmic factors |
| Q24516975 | Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2 |
| Q33888498 | Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor |
| Q39544175 | Exosomal sorting of the viral oncoprotein LMP1 is restrained by TRAF2 association at signalling endosomes |
| Q34682093 | Generation and characterization of a novel recombinant antibody against LMP1-TES1 of Epstein-Barr virus isolated by phage display |
| Q34008771 | HIV-1 Nef induces proinflammatory state in macrophages through its acidic cluster domain: involvement of TNF alpha receptor associated factor 2. |
| Q33642411 | Hepatitis C virus core protein enhances NF-kappaB signal pathway triggering by lymphotoxin-beta receptor ligand and tumor necrosis factor alpha. |
| Q37587096 | High molecular weight complex analysis of Epstein-Barr virus Latent Membrane Protein 1 (LMP-1): structural insights into LMP-1's homo-oligomerization and lipid raft association |
| Q40595025 | High physiological levels of LMP1 result in phosphorylation of eIF2 alpha in Epstein-Barr virus-infected cells |
| Q34479733 | IL-1 receptor-associated kinase 1 is critical for latent membrane protein 1-induced p65/RelA serine 536 phosphorylation and NF-kappaB activation |
| Q33786551 | Interaction of tumor necrosis factor receptor-associated factor signaling proteins with the latent membrane protein 1 PXQXT motif is essential for induction of epidermal growth factor receptor expression |
| Q33834888 | Interferon regulatory factor 7 mediates activation of Tap-2 by Epstein-Barr virus latent membrane protein 1. |
| Q33870488 | Intracellular signaling molecules activated by Epstein-Barr virus for induction of interferon regulatory factor 7. |
| Q39685776 | LMP-1's transmembrane domains encode multiple functions required for LMP-1's efficient signaling |
| Q33890869 | LMP1 signal transduction differs substantially from TNF receptor 1 signaling in the molecular functions of TRADD and TRAF2 |
| Q35139273 | LMP1 transmembrane domain 1 and 2 (TM1-2) FWLY mediates intermolecular interactions with TM3-6 to activate NF-kappaB |
| Q39777437 | LMP1, a viral relative of the TNF receptor family, signals principally from intracellular compartments |
| Q35122447 | Latent infection membrane protein transmembrane FWLY is critical for intermolecular interaction, raft localization, and signaling |
| Q24682515 | Latent membrane protein 1 of Epstein-Barr virus induces CD83 by the NF-kappaB signaling pathway |
| Q39593467 | Latent membrane protein 1 of Epstein-Barr virus inhibits as well as stimulates gene expression |
| Q33891012 | Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins |
| Q34250209 | Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule. |
| Q37535521 | Marek's disease is a natural model for lymphomas overexpressing Hodgkin's disease antigen (CD30) |
| Q33815241 | Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus latent membrane protein 1 C-terminal activation regions 1 and 2. |
| Q43003742 | Modification of Cepsilon mRNA expression by EBV-encoded latent membrane protein 1. |
| Q34225554 | Molecular virology of Epstein-Barr virus |
| Q36961875 | Nuclear factor kappa B-dependent activation of the antiapoptotic bfl-1 gene by the Epstein-Barr virus latent membrane protein 1 and activated CD40 receptor. |
| Q24300115 | PRA1 promotes the intracellular trafficking and NF-kappaB signaling of EBV latent membrane protein 1 |
| Q42775424 | Regulation of CD30 antigen expression and its potential significance for human disease |
| Q36403897 | Requirement for TRAF3 in signaling by LMP1 but not CD40 in B lymphocytes |
| Q33784729 | Role of the TRAF binding site and NF-kappaB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expression |
| Q33822504 | Signaling activities of gammaherpesvirus membrane proteins |
| Q33772240 | Simian homologues of human herpesvirus 8 |
| Q35634395 | TRAF1 Coordinates Polyubiquitin Signaling to Enhance Epstein-Barr Virus LMP1-Mediated Growth and Survival Pathway Activation |
| Q38359234 | TRAF1 is a critical regulator of JNK signaling by the TRAF-binding domain of the Epstein-Barr virus-encoded latent infection membrane protein 1 but not CD40. |
| Q28361340 | TRAF6 is a critical mediator of signal transduction by the viral oncogene latent membrane protein 1 |
| Q39578471 | The 30-base-pair deletion in Chinese variants of the Epstein-Barr virus LMP1 gene is not the major effector of functional differences between variant LMP1 genes in human lymphocytes. |
| Q35076801 | The Epstein-Barr virus BRRF1 protein, Na, induces lytic infection in a TRAF2- and p53-dependent manner |
| Q33882153 | The Epstein-Barr virus and its association with human cancers |
| Q34327176 | The Epstein-Barr virus latent membrane protein 1 putative Janus kinase 3 (JAK3) binding domain does not mediate JAK3 association or activation in B-lymphoma or lymphoblastoid cell lines |
| Q24554457 | The Epstein-Barr virus oncoprotein latent membrane protein 1 engages the tumor necrosis factor receptor-associated proteins TRADD and receptor-interacting protein (RIP) but does not induce apoptosis or require RIP for NF-kappaB activation |
| Q95789811 | The collagen repeat sequence is a determinant of the degree of herpesvirus saimiri STP transforming activity |
| Q34089485 | The expression and function of Epstein-Barr virus encoded latent genes |
| Q34384112 | The germinal center kinase TNIK is required for canonical NF-κB and JNK signaling in B-cells by the EBV oncoprotein LMP1 and the CD40 receptor |
| Q35140197 | The molecular basis for the generation of Hodgkin and Reed-Sternberg cells in Hodgkin's lymphoma |
| Q40997583 | The plasmid replicon of EBV consists of multiple cis-acting elements that facilitate DNA synthesis by the cell and a viral maintenance element |
| Q39596927 | The residues between the two transformation effector sites of Epstein-Barr virus latent membrane protein 1 are not critical for B-lymphocyte growth transformation |
| Q24685892 | The viral etiology of AIDS-associated malignancies |
| Q35192167 | Thermodynamic characterization of the interaction between TRAF2 and tumor necrosis factor receptor peptides by isothermal titration calorimetry |
| Q39732619 | Transmembrane domains 1 and 2 of the latent membrane protein 1 of Epstein-Barr virus contain a lipid raft targeting signal and play a critical role in cytostasis |
| Q37021555 | Tumor-derived variants of Epstein-Barr virus latent membrane protein 1 induce sustained Erk activation and c-Fos |
Search more.